The probiotic infant and child formula in Europe is expected to grow from US$ 826.43 million in 2022 to US$ 1,755.33 million by 2028. It is estimated to grow at a CAGR of 13.4% from 2022 to 2028.
Surge in Working Women Population
Breastmilk is the ideal food for infants as it is safe, clean, and contains antibodies that help protect against many common childhood illnesses. Breastmilk provides the child with all the energy and nutrients that are required for the first few months after birth, and it continues to provide up to half or more of a child’s nutritional needs. According to various surveys and reports, breastfeeding is declining for various reasons, including women’s participation in the labor force. For instance, according to the Office for National Statistics (ONS) of the UK, the employment statistics of mothers grew from 66.2% in 2000 to 75.1% in 2019. Thus, the increased participation of women in the labor force is reducing breastfeeding and is driving the demand for probiotic infant and child formulas. According to the CDC, 17% of babies are supplemented with formula during the first two days of life, and ~35% of babies older than 6 months are fed breastmilk and formula. Thus, the rise in the number of women participating in the labor force is driving the growth of the Europe probiotic infant and child formula market.
Market Overview
The Europe probiotic infant and child formula market is segmented into Germany, France, Italy, the UK, Russia, and the rest of Europe. The market growth is fuelled by a rising fertility rate. According to the European Commission, the total fertility rate in the European Union increased from 1.43 live births per woman in 2001 to 1.50 live births per woman in 2020. Additionally, infant formula and growing-up formula are majorly used by working mothers to provide healthy and nutritious food for their babies. A growing focus on infant care and nutrition, changing lifestyles, rising middle-class population, and increasing purchasing power and disposable income of people in economies (including the UK, Germany, and France) are expected to propel the probiotic infant and child formula market growth in Europe during the forecast period.
Europe Probiotic Infant and Child Formula Market Revenue and Forecast to 2028 (US$ Million)
Europe Probiotic Infant and Child Formula Market Segmentation
The Europe probiotic infant and child formula is segmented into type, distribution channel, and country.
Based on type, the market is segmented into infant formula (0-1 year) and growing-up formula (1-6 years). The growing-up formula (1-6 years) segment registered the larger market share in 2022. Based on distribution channel ,the market is segmented into online and offline. The offline segment held the larger market share in 2022. Based on country, the market is segmented into Germany , France ,Italy , UK , Russia and Rest of Europe. Russia dominated the market share in 2022. Nestlé S.A. ; HiPP GmbH & Company Vertrieb KG ; Abbott Laboratories and Mead Johnson & Company, LLC are the leading companies operating in the probiotic infant and child formula in the region.
TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
2. Key Takeaways
3. Research Methodology
3.1 Scope of the Study
3.2 Research Methodology
3.2.1 Data Collection:
3.2.2 Primary Interviews:
3.2.3 Hypothesis Formulation:
3.2.4 Macro-economic Factor Analysis:
3.2.5 Developing Base Number:
3.2.6 Data Triangulation:
3.2.7 Country Level Data:
4. Europe Probiotic Infant and Child Formula Market Landscape
4.1 Market Overview
4.2 Porter’s Five Forces Analysis
4.2.1 Threat of New Entrants
4.2.2 Bargaining Power of Suppliers
4.2.3 Bargaining Power of Buyers
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes
4.3 Expert Opinion
5. Europe Probiotic Infant and Child Formula Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Focus on Infant Care and Nutrition
5.1.2 Surge in Working Women Population
5.2 Market Restraints
5.2.1 Stringent Rules and Regulations Pertaining to Infant Formula
5.3 Market Opportunities
5.3.1 Rising Demand for Organic Infant Formula
5.4 Future Trends
5.4.1 Innovations in Probiotic Infant and Child Formula Market
5.5 Impact Analysis of Drivers and Restraints
6. Probiotic Infant and Child Formula – Europe Market Analysis
6.1 Probiotic Infant and Child Formula Market Overview
6.2 Europe Probiotic Infant and Child Formula Market –Revenue and Forecast to 2028 (US$ Million)
7. Europe Probiotic Infant and Child Formula Market Analysis – by Type
7.1 Overview
7.2 Europe Probiotic Infant and Child Formula Market, by Type (2021 and 2028)
7.3 Infant Formula (0-1 Year)
7.3.1 Overview
7.3.2 Europe Infant Formula (0-1 Year): Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Growing-Up Formula (1-6 Years)
7.4.1 Overview
7.4.2 Europe Growing-Up Formula (1-6 Year): Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
8. Europe Probiotic Infant and Child Formula Market Analysis – by Distribution Channel
8.1 Overview
8.2 Europe Probiotic Infant and Child Formula Market, by Distribution Channel (2021 and 2028)
8.3 Online
8.3.1 Overview
8.3.2 Europe Online: Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Offline
8.4.1 Overview
8.4.2 Europe Offline: Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Probiotic Infant and Child Formula Market – Country Analysis
9.1 Europe: Probiotic Infant and Child Formula Market
9.1.1 Europe: Probiotic Infant and Child Formula Market –Revenue and Forecast to 2028 (US$ Million)
9.1.2 Europe: Probiotic Infant and Child Formula Market, by Key Country
9.1.2.1 Germany: Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
9.1.2.1.1 Germany: Probiotic Infant and Child Formula Market, By Type
9.1.2.1.2 Germany: Probiotic Infant and Child Formula Market, by Distribution Channel
9.1.2.2 France: Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
9.1.2.2.1 France: Probiotic Infant and Child Formula Market, By Type
9.1.2.2.2 France: Probiotic Infant and Child Formula Market, by Distribution Channel
9.1.2.3 UK: Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
9.1.2.3.1 UK: Probiotic Infant and Child Formula Market, By Type
9.1.2.3.2 UK: Probiotic Infant and Child Formula Market, by Distribution Channel
9.1.2.4 Italy: Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
9.1.2.4.1 Italy: Probiotic Infant and Child Formula Market, By Type
9.1.2.4.2 Italy: Probiotic Infant and Child Formula Market, by Distribution Channel
9.1.2.5 Russia: Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
9.1.2.5.1 Russia: Probiotic Infant and Child Formula Market, By Type
9.1.2.5.2 Russia: Probiotic Infant and Child Formula Market, by Distribution Channel
9.1.2.6 Rest of Europe: Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
9.1.2.6.1 Rest of Europe: Probiotic Infant and Child Formula Market, By Type
9.1.2.6.2 Rest of Europe: Probiotic Infant and Child Formula Market, by Distribution Channel
10. Industry Landscape
10.1 Overview
10.2 New Product Development
11. Company Profiles
11.1 Nestlé S.A.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 HiPP GmbH & Company Vertrieb KG
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Abbott Laboratories
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Mead Johnson & Company, LLC.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Word Index
LIST OF TABLES
Table 1. Europe Probiotic Infant and Child Formula Market –Revenue and Forecast to 2028 (US$ Million)
Table 2. Europe: Probiotic Infant and Child Formula Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. Europe: Probiotic Infant and Child Formula Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany Probiotic Infant and Child Formula Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany Probiotic Infant and Child Formula Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 6. France Probiotic Infant and Child Formula Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 7. France Probiotic Infant and Child Formula Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 8. UK Probiotic Infant and Child Formula Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 9. UK Probiotic Infant and Child Formula Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 10. Italy Probiotic Infant and Child Formula Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. Italy Probiotic Infant and Child Formula Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 12. Russia Probiotic Infant and Child Formula Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 13. Russia Probiotic Infant and Child Formula Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 14. Rest of Europe Probiotic Infant and Child Formula Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 15. Rest of Europe Probiotic Infant and Child Formula Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 16. List of Abbreviation
LIST OF FIGURES
Figure 1. Europe Probiotic Infant and Child Formula Market Segmentation
Figure 2. Europe Probiotic Infant and Child Formula Market Segmentation – By Country
Figure 3. Europe Probiotic Infant and Child Formula Market Overview
Figure 4. Europe Probiotic Infant and Child Formula Market: By Type
Figure 5. Europe Probiotic Infant and Child Formula Market: By Country
Figure 6. Porter’s Five Forces Analysis: Probiotic Infant and Child Formula Market
Figure 7. Expert Opinion
Figure 8. Europe Probiotic Infant and Child Formula Market Impact Analysis of Drivers and Restraints
Figure 9. Europe: Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Europe: Probiotic Infant and Child Formula Market Revenue Share, By Type (2021 and 2028)
Figure 11. Europe Infant Formula (0-1 Year): Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Europe Growing-Up Formula (1-6 Year): Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Europe: Probiotic Infant and Child Formula Market Revenue Share, by Distribution Channel (2021 and 2028)
Figure 14. Europe Online: Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Europe Offline: Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Europe: Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Europe: Probiotic Infant and Child Formula Market Revenue Share, by Key Country (2021 and 2028)
Figure 18. Germany: Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. France: Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. UK: Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Italy: Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Russia: Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Rest of Europe: Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe Probiotic Infant and Child Formula Market.
● Highlights key business priorities in order to assist companies to realign their business strategies.
● The key findings and recommendations highlight crucial progressive industry trends in Europe Probiotic Infant and Child Formula Market, thereby allowing players across the value chain to develop effective long-term strategies.
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
● Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
● Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
The List of Companies – Europe Probiotic Infant and Child Formula Market
● Nestlé S.A.
● HiPP GmbH & Company Vertrieb KG
● Abbott Laboratories
● Mead Johnson & Company, LLC
At 13.4% CAGR, the Europe Probiotic Infant and Child Formula Market is speculated to be worth US$ 1,755.33 million by 2028, says The Insight Partners
According to The Insight Partners’ research, the Europe probiotic infant and child formula market was valued at US$ 826.43 million in 2022 and is expected to reach US$ 1,755.33 million by 2028, registering an annual growth rate of 13.4% from 2022 to 2028. Growing focus on infant care and nutrition and surge in working women population are the critical factors attributed to the market expansion.
In recent years, there has been an increased focus on infant care and providing the optimum amount of nutrition to the child as it will boost the child’s early development. According to reports from UNICEF and Foundation for Brain Development and Learning, the 1,000 days between the woman’s pregnancy and the child’s second birthday provide a critical window of opportunity to shape a child’s brain development. In the first 1,000 days, the brain grows more quickly compared to any other time in a person’s life, and the child needs the right nutrition at the right time to support the brain’s development. Further, different brain processes such as myelination will require different nutrients, and the deficiency of such nutrients during the peak growth period will have a detrimental impact on the child. Thus, the need for the right nutrient at an early stage of a child’s life is driving the demand for probiotic infant and child formula. Parents are increasingly providing probiotics and vitamin supplements to their children to improve their digestive health, general health, immune system, and heart health. Furthermore, the inclusion of probiotics in infant formulas promotes a balance of good bacteria in the child’s intestines and offsets the growth of “unfriendly” organisms that could cause infections and inflammation. Thus, the growing focus on infant care and nutrition is driving the growth of the Europe probiotic infant and child formula market.
On the contrary, stringent rules and regulations pertaining to infant formula hampers market Europe probiotic infant and child formula market.
Based on type, the market is segmented into infant formula (0-1 year) and growing-up formula (1-6 years). The growing-up formula (1-6 years) segment held 73.25% market share in 2022, amassing US$ 605.38 million. It is projected to garner US$ 1,308.90 million by 2028 to expand at 13.7% CAGR during 2022–2028. Based on distribution channel, the market is segmented into online and offline. The offline segment held 85.39% market share in 2022, amassing US$ 705.71 million. It is projected to garner US$ 1479.63 million by 2028 to expand at 13.1% CAGR during 2022–2028. Based on country, the Europe probiotic infant and child formula market has been categorized into Germany, France, Italy, UK, Russia and Rest of Europe. Our regional analysis states that Russia captured 41.16% market share in 2022. It was assessed at US$ 340.17 million in 2022 and is likely to hit US$ 688.53 million by 2028, exhibiting a CAGR of 12.5% during the forecast period. Key players dominating the Europe probiotic infant and child formula market are Nestlé S.A.; HiPP GmbH & Company Vertrieb KG; Abbott Laboratories and Mead Johnson & Company, LLC.
In, 2022; Nestle China launched new infant formula via CBEC. In ,2021; Abbott Laboratories ABT launched the Similac 360 Total Care.
We provide our clients with insightful market research reports and competitive intelligence that helps them stay ahead of the curve.
Business-era specializes in accelerating growth and providing improved brand value to organizations in the competitive market. We synergize with organizations to connect clients and businesses.